{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T02:34:29Z","timestamp":1792550069168,"version":"4.5.0"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T00:00:00Z","timestamp":1598659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Fungal coinfection is a recognized complication of respiratory virus infections, increasing morbidity and mortality, but can be readily treated if diagnosed early. An increasing number of small studies describing aspergillosis in coronavirus disease 2019 (COVID-19) patients with severe respiratory distress are being reported, but comprehensive data are lacking. The aim of this study was to determine the incidence, risk factors, and impact of invasive fungal disease in adult COVID-19 patients with severe respiratory distress.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>An evaluation of a national, multicenter, prospective cohort evaluation of an enhanced testing strategy to diagnose invasive fungal disease in COVID-19 intensive care patients. Results were used to generate a mechanism to define aspergillosis in future COVID-19 patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>One-hundred and thirty-five adults (median age: 57, M\/F: 2.2\/1) were screened. The incidence was 26.7% (14.1% aspergillosis, 12.6% yeast infections). The overall mortality rate was 38%; 53% and 31% in patients with and without fungal disease, respectively (P = .0387). The mortality rate was reduced by the use of antifungal therapy (mortality: 38.5% in patients receiving therapy vs 90% in patients not receiving therapy (P = .008). The use of corticosteroids (P = .007) and history of chronic respiratory disease (P = .05) increased the likelihood of aspergillosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Fungal disease occurs frequently in critically ill, mechanically ventilated COVID-19 patients. The survival benefit observed in patients receiving antifungal therapy implies that the proposed diagnostic and defining criteria are appropriate. Screening using a strategic diagnostic approach and antifungal prophylaxis of patients with risk factors will likely enhance the management of COVID-19 patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/cid\/ciaa1298","type":"journal-article","created":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T15:13:46Z","timestamp":1598627626000},"page":"e1634-e1644","source":"Crossref","is-referenced-by-count":336,"title":["A National Strategy to Diagnose Coronavirus Disease 2019\u2013Associated Invasive Fungal Disease in the Intensive Care Unit"],"prefix":"10.1093","volume":"73","author":[{"given":"P Lewis","family":"White","sequence":"first","affiliation":[{"name":"Public Health Wales Microbiology Cardiff, University Hospital of Wales, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishi","family":"Dhillon","sequence":"additional","affiliation":[{"name":"Public Health Wales Microbiology Cardiff, University Hospital of Wales, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Cordey","sequence":"additional","affiliation":[{"name":"Public Health Wales Microbiology Cardiff, University Hospital of Wales, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harriet","family":"Hughes","sequence":"additional","affiliation":[{"name":"Public Health Wales Microbiology Cardiff, University Hospital of Wales, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Faggian","sequence":"additional","affiliation":[{"name":"Public Health Wales Microbiology Cardiff, University Hospital of Wales, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuchita","family":"Soni","sequence":"additional","affiliation":[{"name":"Public Health Wales Microbiology Cardiff, University Hospital of Wales, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Pandey","sequence":"additional","affiliation":[{"name":"Intensive Care Medicine, University Hospital of Wales, Heath Park, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harriet","family":"Whitaker","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University Hospital of Wales, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"May","sequence":"additional","affiliation":[{"name":"Public Health Wales Microbiology Cardiff, University Hospital of Wales, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"Morgan","sequence":"additional","affiliation":[{"name":"Intensive Care Medicine, University Hospital of Wales, Heath Park, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew P","family":"Wise","sequence":"additional","affiliation":[{"name":"Intensive Care Medicine, University Hospital of Wales, Heath Park, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan","family":"Healy","sequence":"additional","affiliation":[{"name":"Public Health Wales Microbiology Swansea, Singleton Hospital, Swansea, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Blyth","sequence":"additional","affiliation":[{"name":"Public Health Wales Microbiology Swansea, Singleton Hospital, Swansea, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica S","family":"Price","sequence":"additional","affiliation":[{"name":"Public Health Wales Microbiology Cardiff, University Hospital of Wales, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorna","family":"Vale","sequence":"additional","affiliation":[{"name":"Public Health Wales Microbiology Cardiff, University Hospital of Wales, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Posso","sequence":"additional","affiliation":[{"name":"Public Health Wales Microbiology Cardiff, University Hospital of Wales, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Kronda","sequence":"additional","affiliation":[{"name":"Public Health Wales Microbiology Cardiff, University Hospital of Wales, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Blackwood","sequence":"additional","affiliation":[{"name":"Public Health Wales Microbiology Cardiff, University Hospital of Wales, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Rafferty","sequence":"additional","affiliation":[{"name":"Public Health Wales Microbiology Cardiff, University Hospital of Wales, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Moffitt","sequence":"additional","affiliation":[{"name":"Public Health Wales Microbiology Cardiff, University Hospital of Wales, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Tsitsopoulou","sequence":"additional","affiliation":[{"name":"Cwm Taf Microbiology Department, Royal Glamorgan, Ynysmaerdy, Rhondda Cynon Taf, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soma","family":"Gaur","sequence":"additional","affiliation":[{"name":"Aneurin Bevan Microbiology Department, Royal Gwent Hospital, Newport, Gwent, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Holmes","sequence":"additional","affiliation":[{"name":"Intensive Care Medicine, University Hospital of Wales, Heath Park, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthijs","family":"Backx","sequence":"additional","affiliation":[{"name":"Public Health Wales Microbiology Cardiff, University Hospital of Wales, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,8,29]]},"reference":[{"key":"2021100522233128700_CIT0001","first-page":"e01122","article-title":"Predicting invasive aspergillosis in hematology patients by combining clinical and genetic risk factors with early diagnostic biomarkers","volume":"56","author":"White","year":"2017","journal-title":"J Clin Microbiol"},{"key":"2021100522233128700_CIT0002","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S2213-2600(18)30274-1","article-title":"Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study","volume":"6","author":"Schauwvlieghe","year":"2018","journal-title":"Lancet Respir Med"},{"key":"2021100522233128700_CIT0003","article-title":"Oseltamivir affects host defense against invasive pulmonary aspergillosis","author":"Dewi","year":"2018"},{"key":"2021100522233128700_CIT0004","article-title":"D","author":"Chen","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2021100522233128700_CIT0005","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1016\/S2666-5247(20)30027-6","article-title":"Diagnosing COVID-19-associated pulmonary aspergillosis","volume":"1","author":"Verweij","year":"2020","journal-title":"Lancet Microbe"},{"key":"2021100522233128700_CIT0006","article-title":"Pre-empting and mitigating the risk that invasive pulmonary fungal infections present to patients with COVID-19","author":"Armstrong-James","year":"2020","journal-title":"Euro Resp J"},{"key":"2021100522233128700_CIT0007","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"N Engl J Med"},{"key":"2021100522233128700_CIT0008","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3390\/jof6020091","article-title":"COVID-19 associated pulmonary aspergillosis (CAPA)-from immunology to treatment","volume":"6","author":"Arastehfar","year":"2020","journal-title":"Fungi (Basel)"},{"key":"2021100522233128700_CIT0009","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S1473-3099(20)30200-0","article-title":"Clinical and virological data of the first cases of COVID-19 in Europe: a case series","volume":"20","author":"Lescure","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"2021100522233128700_CIT0010","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(20)30237-X","article-title":"Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19","author":"Alanio","year":"2020","journal-title":"Lancet Resp Med"},{"key":"2021100522233128700_CIT0011","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/myc.13096","article-title":"COVID-19 associated pulmonary aspergillosis","volume":"63","author":"Koehler","year":"2020","journal-title":"Mycoses"},{"key":"2021100522233128700_CIT0012","doi-asserted-by":"crossref","first-page":"104364","DOI":"10.1016\/j.jcv.2020.104364","article-title":"Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China","volume":"127","author":"Zhang","year":"2020","journal-title":"J Clin Virol"},{"key":"2021100522233128700_CIT0013","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa530","article-title":"Bacterial and fungal co-infection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing","author":"Rawson","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2021100522233128700_CIT0014","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.3201\/eid2607.201603","article-title":"Fatal invasive aspergillosis and coronavirus disease in an immunocompetent patient","volume":"26","author":"Blaize","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"2021100522233128700_CIT0015","doi-asserted-by":"crossref","first-page":"100971","DOI":"10.1016\/j.mycmed.2020.100971","article-title":"Invasive fungal diseases during COVID-19: we should be prepared","volume":"30","author":"Gangneux","year":"2020","journal-title":"J Mycol Med"},{"key":"2021100522233128700_CIT0016","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jinf.2013.04.020","article-title":"Prevention and diagnosis of invasive fungal disease in high-risk patients within an integrative care pathway","volume":"67","author":"Barnes","year":"2013","journal-title":"J Infect"},{"key":"2021100522233128700_CIT0017","volume-title":"Sepsis: recognition, diagnosis and early management","author":"NICE Guideline 51"},{"key":"2021100522233128700_CIT0018","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1164\/rccm.201111-1978OC","article-title":"A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients","volume":"186","author":"Blot","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2021100522233128700_CIT0019","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2021100522233128700_CIT0020","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/MCC.0000000000000637","article-title":"Diagnosing invasive pulmonary aspergillosis in ICU patients: putting the puzzle together","volume":"25","author":"Blot","year":"2019","journal-title":"Curr Opin Crit Care"},{"key":"2021100522233128700_CIT0021","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ijantimicag.2017.05.017","article-title":"Drivers and impact of antifungal therapy in critically ill patients with Aspergillus-positive respiratory tract cultures","volume":"50","author":"Paiva","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"2021100522233128700_CIT0022","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1128\/JCM.01767-09","article-title":"Aspergillus PCR: one step closer to standardization","volume":"48","author":"White","year":"2010","journal-title":"J Clin Microbiol"},{"key":"2021100522233128700_CIT0023","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jcrc.2016.06.026","article-title":"Comparison of 1,3-\u03b2-d-glucan with galactomannan in serum and bronchoalveolar fluid for the detection of Aspergillus species in immunosuppressed mechanical ventilated critically ill patients","volume":"36","author":"Lahmer","year":"2016","journal-title":"J Crit Care"},{"key":"2021100522233128700_CIT0024","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1086\/499949","article-title":"The evolution and evaluation of a whole blood polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a routine clinical setting","volume":"42","author":"White","year":"2006","journal-title":"Clin Infect Dis"},{"key":"2021100522233128700_CIT0025","doi-asserted-by":"crossref","first-page":"E97","DOI":"10.1148\/radiol.2020201473","article-title":"CO-RADS: a categorical CT assessment scheme for patients suspected of having COVID-19-definition and evaluation","volume":"296","author":"Prokop","year":"2020","journal-title":"Radiology"},{"key":"2021100522233128700_CIT0026","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/myc.12831","article-title":"Treatment outcomes in patients with proven\/probable vs possible invasive mould disease in a phase III trial comparing isavuconazole vs voriconazole","volume":"61","author":"Maertens","year":"2018","journal-title":"Mycoses"},{"key":"2021100522233128700_CIT0027","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.202005-2018LE","article-title":"Detection of invasive pulmonary aspergillosis in COVID-19 with non-directed bronchoalveolar lavage","author":"Van Biesen","year":"2020","journal-title":"Am J Resp Crit Care Med"},{"key":"2021100522233128700_CIT0028","article-title":"Epidemiology of invasive pulmonary aspergillosis among COVID-19 intubated patients: a prospective study","author":"Bartoletti","journal-title":"Clin Infect Dis"},{"key":"2021100522233128700_CIT0029","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1164\/rccm.200704-606OC","article-title":"Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients","volume":"177","author":"Meersseman","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"2021100522233128700_CIT0030","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1164\/rccm.202004-1038LE","article-title":"COVID-19 associated pulmonary aspergillosis","volume":"202","author":"Van Arkel","year":"2020","journal-title":"Am J Resp Crit Care Med"},{"key":"2021100522233128700_CIT0031","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1016\/S2666-5247(20)30065-3","article-title":"COVID-19 and fungal superinfection","volume":"1","author":"Heard","year":"2020","journal-title":"Lancet Microbe"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciaa1298\/33895425\/ciaa1298.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/73\/7\/e1634\/40511685\/ciaa1298.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/73\/7\/e1634\/40511685\/ciaa1298.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T19:01:11Z","timestamp":1633719671000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/73\/7\/e1634\/5899192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,29]]},"references-count":31,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,8,29]]},"published-print":{"date-parts":[[2021,10,5]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaa1298","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,10,1]]},"published":{"date-parts":[[2020,8,29]]}}}